Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attackYuan Fang, Ying–Hong Shi, Weiren Liu et al.|Hepatology|2022Cited by 158
Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesisYufu Zhou, Ying–Hong Shi, Shushu Song et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 72
Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic CholangiocarcinomaZheng Tang, Ying–Hong Shi, Xi‐Fei Jiang et al.|Journal of Cancer|2019Cited by 50
Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resectionWei‐Feng Qu, Ying–Hong Shi, Pei‐Yun Zhou et al.|Annals of Translational Medicine|2020Cited by 49
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinomaMeng‐Xin Tian, Ying–Hong Shi, Wei‐Ren Liu et al.|BMC Medicine|2019Cited by 44